BIO-key International (BKYI)
Nasdaq Market Closed
Last updated
- Market Cap
- $5,155,460
- P/E
- —
- P/FCF
- —
- P/S
- 0.8
- Enterprise Value
- $3,571,762
- Sector
- —
- Industry
- —
- Address
- —
BIO-key International, Inc. Q1 2026 Earnings Call Summary
BIO-key International, Inc. Q4 2025 Earnings Call Summary
TD SYNNEX Deepens Public Sector Security With BIO Key Biometrics Partnership
BIO-key International Enters into $3.1 Million Warrant Inducement Transaction
BC-Most Active Stocks
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $5,155,460
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $3,571,762
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.05
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.8
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -1.04
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.55
- EPS
- -6.11
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -$4,198,820
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -135.45%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -81.24%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.14
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.41
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.3
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.7
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $11,105
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 4.75
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 2.15M | 1.08M | 1.55M | 1.7M | 1.61M |
| Cost of revenue | 376.3K | 271.37K | 357.99K | 464.18K | 279.5K |
| Gross profit | 1.77M | 812.41K | 1.19M | 1.23M | 1.33M |
| Operating income | -157.71K | -4.21M | -892.19K | -1.08M | -640.64K |
| EBITDA | -46.96K | -1.77M | -772.15K | -861.93K | -496.07K |
| Net income | -205.04K | -4.29M | -964.85K | -1.17M | -736.55K |
| Income taxes | — | 16.5K | — | — | — |
| Interest expense | -27.17K | 13.93K | -13.17K | -85.64K | -35.91K |
| Other operating expenses | 0 | 2.5M | 0 | 0 | 0 |
| Total operating expenses | 1.93M | 5.02M | 2.08M | 2.32M | 1.97M |
| Basic EPS | -0.2 | -5.77 | -1.5 | -2 | -1.57 |
| Diluted EPS | -0.2 | -5.77 | -1.5 | -2 | -1.57 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 8.16M | 8.3M | 10.11M | 10.52M | 11.18M |
| Total liabilities | 3.26M | 3.2M | 4.07M | 3.66M | 3.66M |
| Total equity | 4.89M | 5.11M | 6.05M | 6.85M | 7.53M |
| Cash & equivalents | 2.25M | 2.69M | 2.04M | 2.28M | 3.13M |
| Current assets | 4.49M | 4.54M | 3.75M | 4.04M | 4.59M |
| Current liabilities | 3.19M | 3.1M | 2.96M | 3.53M | 3.47M |
| Accounts payable | 514.2K | 507.36K | 655.65K | 889.03K | 568.84K |
| Receivables | 1.57M | 1.22M | 959.5K | 983.53K | 803.28K |
| Inventories | 338.4K | 370.88K | 394.18K | 318.54K | 357.84K |
| Long-term debt | — | — | 1M | — | 11.67K |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -358K | -1.83M | -1.12M | -880.01K | -835.31K |
| Investing cash flow | — | -4.64K | -1.33K | -1.48K | -4.57K |
| Financing cash flow | -38.18K | 2.46M | 962.51K | -35.72K | 3.53M |
| Change in cash | -446.68K | 654.81K | -235.49K | -858.41K | 2.7M |
| Net income | -205.04K | -4.29M | -964.85K | -1.17M | -736.55K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | DEF 14A — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | ARS — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — LACOUS MIRA K | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| form 4 | Form 4 — Sullivan James David | View Filing | |
| edgar index | 10-Q — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 10-K/A — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 10-K — BIO KEY INTERNATIONAL INC | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | NT 10-Q — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | NT 10-K — BIO KEY INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | PRE 14A — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| form 4 | Form 4 — Sullivan James David | View Filing | |
| form 4 | Form 4 — LACOUS MIRA K | View Filing | |
| edgar index | 424B3 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | EFFECT — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | CORRESP — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | S-1 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 10-Q — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4/A — BIO KEY INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — DEPASQUALE MICHAEL W | View Filing | |
| form 4 | Form 4 — LACOUS MIRA K | View Filing | |
| form 4 | Form 4 — Sullivan James David | View Filing | |
| form 4 | Form 4 — Welch Cecilia C | View Filing | |
| edgar index | S-8 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | S-8 — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 4 — BIO KEY INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — Sullivan James David | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | SCHEDULE 13G/A — BIO KEY INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — BIO KEY INTERNATIONAL INC | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free